|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 532-540, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
M Boban, DF Stowe, JP Kampine, AH Goldberg and ZJ Bosnjak
The cardiac effects of 2,3-butanedione monoxime on electrical and
mechanical function, rhythm, oxygen utilization, and coronary flow
responsiveness, particularly during severe ischemia and reperfusion, have
not been studied. After perfusing hearts at 55 mm Hg, coronary perfusion
was interrupted for 30 minutes and was then reestablished at the control
perfusion pressure for 40 minutes. Hearts were divided into four groups (n
= 10 each) treated with 0, 3, 5, or 10 mmol/L of 2,3- butanedione monoxime
added to the perfusate for 10 minutes before and during ischemia and for
the first 10 minutes of reperfusion. An additional nonischemic group served
as a time control. Variables monitored were heart rate, atrioventricular
conduction time, cardiac rhythm, isovolumetric systolic and diastolic left
ventricular pressure, maximum rate of left ventricular pressure change,
coronary flow, myocardial oxygen consumption, and the ratio of oxygen
delivery to myocardial oxygen consumption. Before ischemia, 2,3-butanedione
monoxime significantly decreased isovolumetric left ventricular systolic
pressure and increased the ratio of oxygen delivery to myocardial oxygen
consumption in a dose-dependent manner, with only slight changes in heart
rate and atrioventricular time with 10 mmol/L of 2,3-butanedione, monoxime.
After 40 minutes of reperfusion, isovolumetric left ventricular systolic
pressure recovered to 81 +/- 5% and 83 +/- 2% of the initial control values
for the 5 and 10 mmol/L 2,3- butanedione monoxime groups. This was
significantly greater than the recovery for the 0 and 3 mmol/L
2,3-butanedione monoxime groups, 59 +/- 3% and 63 +/- 4%, respectively.
Similarly, the duration of ventricular fibrillation and of tachycardia was
significantly lower, coronary flow reserve was better preserved, and
myocardial oxygen consumption was greater with reperfusion in the 5 and 10
mmol/L 2,3-butanedione monoxime groups than in the 0 mmol/L 2,3-butanedione
monoxime group. This study shows that relatively low concentrations of
2,3-butanedione monoxime, given before global ischemia and early during
reperfusion of isolated hearts, can protect against dysrhythmias and
improve return of myocardial and vascular function.
ARTICLES
Effects of 2,3-butanedione monoxime in isolated hearts: protection during reperfusion after global ischemia
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee 53226.
This article has been cited by other articles:
![]() |
M. Matsumoto-Ida, M. Akao, T. Takeda, M. Kato, and T. Kita Real-Time 2-Photon Imaging of Mitochondrial Function in Perfused Rat Hearts Subjected to Ischemia/Reperfusion Circulation, October 3, 2006; 114(14): 1497 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. S. Camara, Q. Chen, S. S. Rhodes, M. L. Riess, and D. F. Stowe Negative inotropic drugs alter indexes of cytosolic [Ca2+]-left ventricular pressure relationships after ischemia Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H667 - H680. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Qian, R. J. Sung, S.-F. Lin, R. Province, and W. T. Clusin Spatial heterogeneity of action potential alternans during global ischemia in the rabbit heart Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2722 - H2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cheng, K. A. Mowrey, V. Nikolski, P. J. Tchou, and I. R. Efimov Mechanisms of shock-induced arrhythmogenesis during acute global ischemia Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2141 - H2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Jayawant, E. R. Stephenson Jr, and R. J. Damiano Jr 2,3-Butanedione monoxime cardioplegia: advantages over hyperkalemia in blood-perfused isolated hearts Ann. Thorac. Surg., March 1, 1999; 67(3): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Habazettl, J. Voigtlander, R. Leiderer, and K. Messmer Efficacy of myocardial initial reperfusion with 2,3 butanedione monoxime after cardioplegic arrest is time-dependent Cardiovasc Res, March 1, 1998; 37(3): 684 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Stowe, M. Boban, D. L. Roerig, D. Chang, B. W. Palmisano, and Z. J. Bosnjak Effects of L-Arginine and N{omega}-Nitro-L-Arginine Methyl Ester on Cardiac Perfusion and Function After 1-Day Cold Preservation of Isolated Hearts Circulation, March 18, 1997; 95(6): 1623 - 1634. [Abstract] [Full Text] |
||||
![]() |
J. P. Slater, M. M.R. Amirhamzeh, O. J. Yano, A. S. Shah, J. P. Starr, R. J. Kaplon, W. Burfeind, P. Pepino, R. E. Michler, E. A. Rose, et al. Discriminating Between Preservation and Reperfusion Injury in Human Cardiac Allografts Using Heart Weight and Left Ventricular Mass Circulation, November 1, 1995; 92(9): 223 - 227. [Abstract] [Full Text] |
||||
![]() |
Y. Cheng, K. A. Mowrey, V. Nikolski, P. J. Tchou, and I. R. Efimov Mechanisms of shock-induced arrhythmogenesis during acute global ischemia Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2141 - H2151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |